Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions. METHODS: We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit. RESULTS: Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year. CONCLUSIONS: Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 1×
“Background Opioid and other drug dependence are chronic medical conditions, which can be treated in an outpatient primary care setting as other illnesses are [1].”
BackgroundFudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577
Integrating Primary Medical Care With Addiction Treatment: A Randomized Controlled Trial
Weisner, C., Mertens, J., Parthasarathy, S., Moore, C., & Lu, Y. (2001) · JAMA · doi:10.1001/jama.286.14.1715 · Cited by 368
Altice, F. L., Bruce, R. D., Lucas, G. M., Lum, P. J., Korthuis, P. T., Flanigan, T. P., Cunningham, C. O., Sullivan, L. E., Vergara-Rodriguez, P., Fiellin, D. A., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318209751e · Cited by 256
Mertens, J. R., Lu, Y. W., Parthasarathy, S., Moore, C., & Weisner, C. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2511 · Cited by 216
Providing medical care to methadone clinic patients: referral vs on-site care.
Umbricht-Schneiter, A., Ginn, D. H., Pabst, K. M., & Bigelow, G. E. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.2.207 · Cited by 176
O’Connor, P., Oliveto, A., Shi, J., Triffleman, E., Carroll, K., Kosten, T., Rounsaville, B., Pakes, J., & Schottenfeld, R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00194-6 · Cited by 174
Brief report: Buprenorphine retention in primary care
Stein, M. D., Cioe, P., & Friedmann, P. D. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0228.x · Cited by 171
Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year
Soeffing, J. M., Martin, L. D., Fingerhood, M., Jasinski, D. R., & Rastegar, D. A. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.05.003 · Cited by 148
Self-citationTreating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings
Mintzer, I. L., Eisenberg, M., Terra, M., MacVane, C., Himmelstein, D. U., & Woolhandler, S. (2007) · The Annals of Family Medicine · doi:10.1370/afm.665 · Cited by 117 · cited 1×
“A number of studies have demonstrated the safety and efficacy of office-based treatment of opioid dependence with sublingual formulations of buprenorphine [2-6].”
BackgroundSullivan, L. E., Chawarski, M., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.12.008 · Cited by 110
Simoens, S., Matheson, C., Bond, C. M., Inkster, K., & Ludbrook, A. (2005) · Lirias · Cited by 107
Friedmann, P. D., Zhang, Z., Hendrickson, J. C., Stein, M. D., & Gerstein, D. R. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.10601.x · Cited by 99
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial
Gibson, A. E., Doran, C. M., Bell, J. R., Ryan, A., & Lintzeris, N. (2003) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05417.x · Cited by 94
Self-perceived Health Among Canadian Opiate Users
Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strıke, C., Myers, T., Shore, R., Hopkins, S., Raftis, S., & Pearson, M. (2004) · Canadian Journal of Public Health · doi:10.1007/bf03405775 · Cited by 93
Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
Barry, D. T., Moore, B. A., Pantalon, M. V., Chawarski, M. C., Sullivan, L. E., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0050-y · Cited by 74
BRIDGE, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00061-9 · Cited by 63
Cullen, W., O'Brien, S., O’Carroll, A., O'Kelly, F. D., & Bury, G. (2009) · BMC Family Practice · doi:10.1186/1471-2296-10-25 · Cited by 59
Friedmann, P. D., Hendrickson, J. C., Gerstein, D. R., Zhang, Z., & Stein, M. D. (2005) · Medical Care · doi:10.1097/01.mlr.0000188913.50489.77 · Cited by 57
On-site medical care in methadone maintenance: Associations with health care use and expenditures
Gourevitch, M. N., Chatterji, P., Deb, N., Schoenbaum, E. E., & Turner, B. J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.07.008 · Cited by 43
Finch, J. W., Kamien, J. B., & Amass, L. (2007) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31809b5df2 · Cited by 39
Laine, C., Lin, Y.-T., Hauck, W. W., & Turner, B. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000178198.79329.89 · Cited by 36
Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United States
Sullivan, L. E., Bruce, R. D., Haltiwanger, D., Lucas, G. M., Eldred, L. J., Finkelstein, R., & Fiellin, D. A. (2006) · Clinical Infectious Diseases · doi:10.1086/508183 · Cited by 34
A Case Series of Buprenorphine/Naloxone Treatment in a Primary Care Practice
Doolittle, B. R., & Becker, W. C. (2011) · Substance Abuse · doi:10.1080/08897077.2011.599256 · Cited by 28
Korthuis, P. T., Asch, S. M., Mancewicz, M., Shapiro, M. F., Mathews, W. C., Cunningham, W. E., McCutchan, J. A., Gifford, A. L., Lee, M. L., & Bozzette, S. A. (2002) · Medical Care · doi:10.1097/00005650-200212000-00014 · Cited by 27
Buprenorphine and HIV Primary Care: New Opportunities for Integrated Treatment
Khalsa, J. H., Vocci, F. J., Altice, F. L., Fiellin, D. A., & Miller, V. (2006) · Clinical Infectious Diseases · doi:10.1086/508179 · Cited by 12
Less Pain, More Gain: Buprenorphine-Naloxone and Patient Retention in Treatment
Renzelli, C. M., & Capretto, N. A. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n03_12 · Cited by 8
Cited by
Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
Srivastava, A., Kahan, M., & Nader, M. (2017) · PubMed · Cited by 104
Hooker, S. A., Sherman, M. D., Lonergan, M. E., Sattler, A. F., Liese, B. S., Justesen, K., Nissly, T. J., & Levy, R. J. (2020) · Journal of Primary Care & Community Health · doi:10.1177/2150132720932017 · Cited by 67
Fox, A. D., Chamberlain, A., Sohler, N., Frost, T., & Cunningham, C. O. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.07.015 · Cited by 62
Austin, E. J., Tsui, J. I., Barry, M. P., Tung, E. L., Glick, S. N., Ninburg, M. H., & Williams, E. C. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108684 · Cited by 59
Patient predictors of substance use disorder treatment initiation in primary care
Ober, A. J., Watkins, K. E., McCullough, C. M., Setodji, C. M., Osilla, K., & Hunter, S. B. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.04.004 · Cited by 50
Metadata
- Authors
- Rowe, T. A., Jacapraro, J. S., & Rastegar, D. A.
- Affiliations
- Yale University (US)
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Corresponding author
- Rowe, Theresa A
- Venue
- Addiction Science & Clinical Practice
- Published
- 2012-10-29
- Volume
- 7
- Issue
- 1
- Pages
- 22-22
- ISSN
- 1940-0632 (ISSN-L)
- 1940-0640
- PMC
- PMC3509402
- OpenAlex
- W1990275197
- Cited by
- 36
- References
- 27
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Addiction Science & Clinical Practice (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Family Practice › Primary Care and Health Outcomes
- Keywords
- buprenorphine, opioid use disorder, primary care, sublingual buprenorphine, chronic disease, comorbidities, underdiagnosis, treatment initiation, opioid use disorder treatment
- MeSH terms
- Adult, Buprenorphine, Chronic Disease, Female, Humans, Insurance Claim Review, Male, Middle Aged, Narcotic Antagonists, Opioid-Related Disorders, Primary Health Care, Retrospective Studies, Socioeconomic Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.